did:plc:6ggbavoq2dj7l5ejry2kchs2
Postdoctoral researcher at WEHI
- Reposted by did:plc:6ggbavoq2dj7l5ejry2kchs21/ 🚀 AEBP2 isn’t what we thought. You were told that AEBP2 promotes PRC2 activity on chromatin. We found the opposite: the most prevalent AEBP2 isoform inhibits PRC2 activity. 👉 surl.li/cgwqcq A thread 🧵
- Reposted by did:plc:6ggbavoq2dj7l5ejry2kchs2We are delighted that @genesdev.bsky.social have selected our (w/ @adrianbracken.bsky.social) Weaver syndrome paper artwork as the November cover! This piece was made by my incredibly talented niece, Gina 'Dna Vinci' Ronan. @ucddublin.bsky.social @tcddublin.bsky.social @ucd-sbbs.bsky.social
- 🚨 NEW ISSUE ALERT!!! 🚨 New Outlook, Review and Research articles online now at Genes & Development. Click on the link to learn more: ➡️ genesdev.cshlp.org/content/39/21-22.toc
- Reposted by did:plc:6ggbavoq2dj7l5ejry2kchs2[Not loaded yet]
- Reposted by did:plc:6ggbavoq2dj7l5ejry2kchs2Absolutely delighted to share our preprint, using functional genomics to uncover a novel dependency in lymphoma that can overcome resistance to targeted therapy. Grateful to co-first author @jamesnolan.bsky.social and co-senior authors @conwayer1.bsky.social and @adrianbracken.bsky.social see👇
- 🧵1/Exciting news in cancer epigenetics! Our latest research, "AEBP2-Directed H3K27me2 Defines a Specific Vulnerability in EZH2-mutant Lymphoma", is now available on www.biorxiv.org/content/10.1.... Here's a thread summarizing our findings!👇 #CancerResearch #Epigenetics #Chromatin #Lymphoma
- Reposted by did:plc:6ggbavoq2dj7l5ejry2kchs2🧵1/Exciting news in cancer epigenetics! Our latest research, "AEBP2-Directed H3K27me2 Defines a Specific Vulnerability in EZH2-mutant Lymphoma", is now available on www.biorxiv.org/content/10.1.... Here's a thread summarizing our findings!👇 #CancerResearch #Epigenetics #Chromatin #Lymphoma
- Great to see @jongminkmg.bsky.social’s preview of our work in @cp-molcell.bsky.social today! www.cell.com/molecular-ce...
- Reposted by did:plc:6ggbavoq2dj7l5ejry2kchs2Online Now: A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma Online now:
